The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

The list prices of obesity drugs Wegovy and Zepbound are over $1,000, but that’s not necessarily what you pay.

P res. Donald Trump says Americans could soon pay far less for GLP-1 medications used for diabetes, obesity, and heart ...

The Trump administration portrays its deals with drug manufacturers as major victories against rising drug prices — but they ...

Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...

Even by dramatically lowering the prices of some of its medications, the drug giant is still outpacing its rivals and nearing ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower ...

One of the biggest gripes around weight loss medications like Wegovy and Zepbound is the high price tag. At $1,000 or more a ...

The voluntary model for states, called GENErating cost Reductions fOr U.S. Medicaid (GENEROUS) allows state Medicaid programs ...

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices ...

The Trump administration is expected to announce deals with Eli Lilly and Novo Nordisk to cut prices of some weight loss ...